Skip to content Skip to navigation

Proteomics of ADNIV

We are using proteomics to study the vitreous fluid from eyes with ADNIV.


Dec 21 2017 | Stanford Report | Posted In: 20/20 Blog, Press
Researchers are studying proteins in the eye to find existing drugs that can treat a rare eye disease known as neovascular inflammatory vitreoretinopathy that causes blindness.   Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of...


Therapeutic drug repositioning using personalized proteomics of liquid biopsies, Velez, Gabriel, Bassuk Alexander G., Colgan Diana, Tsang Stephen H., and Mahajan Vinit B. , JCI insight, Volume 2, (2017)